Global Aesthetic Medicine Market Report 2024: Market Size, CAGR, Lucrative Segments And Top Regions

Overview and Scope
Aesthetic medicine refers to a growing field of medicine that is separate from plastic surgery and offers minimally invasive medical procedures to improve patients' pleasure with their physical appearance. These elective operations are carried out on healthy adult patients. The medical aesthetic treatments carried out through these aesthetic medicine products include non-invasive lipolysis, hair restoration and removal, cellulite reduction, wrinkle reduction, skin renewal & resurfacing, and others.

Sizing and Forecast
The aesthetic medicine market size has grown strongly in recent years. It will grow from $62.37 billion in 2023 to $68.57 billion in 2024 at a compound annual growth rate (CAGR) of 9.9%.  The  growth in the historic period can be attributed to rising disposable income and urbanization, growing obese population and increasing popularity of noninvasive and minimally invasive aesthetic procedures.

The aesthetic medicine market size is expected to see strong growth in the next few years. It will grow to $96.66 billion in 2028 at a compound annual growth rate (CAGR) of 9.0%.  The growth in the forecast period can be attributed to increasing elderly population, rapid urbanization and rise in disposable income, increase in mergers and acquisitions. Major trends in the forecast period include product innovations, use of artificial intelligence in aesthetics, development of focal radio frequency technology, use of laser-assisted liposuction, and partnerships and collaborations.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/aesthetic-medicine-global-market-report

Segmentation & Regional Insights
The aesthetic medicine market covered in this report is segmented –
1) By Product: Facial Aesthetic Products, Body Contouring Devices, Cosmetic Implants, Hair Removal Devices, Skin Aesthetic Devices, Other Products
2) By Procedure Type: Invasive Procedures, Non-Invasive Procedures 
3) By End-User: Hospitals And Clinics, Medical Spas And Beauty Centres,  Home Care

North America was the largest region in the aesthetic medicine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aesthetic medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6349&type=smp

Major Driver Impacting Market Growth
The growing obese population across the globe is expected to propel the growth of the aesthetic medicine market. The increase in unhealthy food consumption, lack of physical activity, and parental & postnatal influences are contributing to rapid growth in the obese population across the globe. Individuals with obesity, seek aesthetic medicine for fat reduction, meso/face-lift, and other benefits through various invasive and non-invasive aesthetic medicine procedures. For instance, in July 2021, according to a European health interview survey on the overweight or obese population in Europe conducted by Eurostat, the statistical office of the European Union, reported that 52.7% of the adult population of Europe was overweight. Therefore, the growing number of obese populations across the globe is expected to drive the growth of the aesthetic medicine market.

Key Industry Players
Major companies operating in the aesthetic medicine market report are AbbVie, Johnson & Johnson, Galderma, Bausch Health, Shanghai Fosun Pharmaceutical Co, Cynosure, El.En. S.p.A, Cutera, Merz Pharma, Syneron Candela, Vive Cosmetics, VLCC Personal Care, Kazima Cosmetics Mitsubishi Heavy Industries, Ltd, SoftFil, Sinclair Phama, BIOXIS pharmaceuticals, Premium Aesthetics LLC, Martinex, Medical Esthetic, Ipsen Pharma, Ruby Surgery & Aesthetics, Medicina Estética Regenerativa, Xcite Technologies, ReNue aesthetic medicine, VYDENCE Medical, Julphar, MSD (Musculoskeletal disorders), Next Biosciences, Novartis South Africa, BBI Solutions, Aspen Pharmacare, 54gene, Altis Biologics, Cipla Medpro, Sanofi Genzyme.

The aesthetic medicine market report table of contents includes:
1. Executive Summary

2. Aesthetic Medicine Market Characteristics

3. Aesthetic Medicine Market Trends And Strategies

4. Aesthetic Medicine Market - Macro Economic Scenario

5. Global Aesthetic Medicine Market Size and Growth

.

32. Global Aesthetic Medicine Market Competitive Benchmarking

33. Global Aesthetic Medicine Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Aesthetic Medicine Market

35. Aesthetic Medicine Market Future Outlook and Potential Analysis

36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model